- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Single-Use Technologies for the Biologic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Single-Use Technologies for the Biologic market size is estimated to be worth US$ 4454 million in 2021 and is forecast to a readjusted size of USD 8388.3 million by 2028 with a CAGR of 9.5% during review period. Monoclonal Antibodies accounting for % of the Single-Use Technologies for the Biologic global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Membrane Adsorber segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Single-Use Technologies for the Biologic include Thermo Fisher Scientific, Applikon Biotechnology, GE Healthcare, Pall, and BioPure Technology, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Single-Use Technologies for the Biologic market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Membrane Adsorber
Bioreactors
Disposable Mixing Systems
Tangential Flow Filtration
Tubing and Connectors
Depth Filtration
Buffer Containers
Waste Containers
Market segment by Application, can be divided into
Monoclonal Antibodies
Vaccines
Gene Therapy
Recombinant Proteins
Blood Derivatives
Market segment by players, this report covers
Thermo Fisher Scientific
Applikon Biotechnology
GE Healthcare
Pall
BioPure Technology
Sartorius
Novasep
W. L. Gore and Associates
EMD Millipore
DowDuPont
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Single-Use Technologies for the Biologic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Single-Use Technologies for the Biologic, with revenue, gross margin and global market share of Single-Use Technologies for the Biologic from 2019 to 2022.
Chapter 3, the Single-Use Technologies for the Biologic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Single-Use Technologies for the Biologic market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Single-Use Technologies for the Biologic research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Single-Use Technologies for the Biologic
1.2 Classification of Single-Use Technologies for the Biologic by Type
1.2.1 Overview: Global Single-Use Technologies for the Biologic Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Single-Use Technologies for the Biologic Revenue Market Share by Type in 2021
1.2.3 Membrane Adsorber
1.2.4 Bioreactors
1.2.5 Disposable Mixing Systems
1.2.6 Tangential Flow Filtration
1.2.7 Tubing and Connectors
1.2.8 Depth Filtration
1.2.9 Buffer Containers
1.2.10 Waste Containers
1.3 Global Single-Use Technologies for the Biologic Market by Application
1.3.1 Overview: Global Single-Use Technologies for the Biologic Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Monoclonal Antibodies
1.3.3 Vaccines
1.3.4 Gene Therapy
1.3.5 Recombinant Proteins
1.3.6 Blood Derivatives
1.4 Global Single-Use Technologies for the Biologic Market Size & Forecast
1.5 Global Single-Use Technologies for the Biologic Market Size and Forecast by Region
1.5.1 Global Single-Use Technologies for the Biologic Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Single-Use Technologies for the Biologic Market Size by Region, (2017-2022)
1.5.3 North America Single-Use Technologies for the Biologic Market Size and Prospect (2017-2028)
1.5.4 Europe Single-Use Technologies for the Biologic Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Single-Use Technologies for the Biologic Market Size and Prospect (2017-2028)
1.5.6 South America Single-Use Technologies for the Biologic Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Single-Use Technologies for the Biologic Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Single-Use Technologies for the Biologic Market Drivers
1.6.2 Single-Use Technologies for the Biologic Market Restraints
1.6.3 Single-Use Technologies for the Biologic Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Single-Use Technologies for the Biologic Product and Solutions
2.1.4 Thermo Fisher Scientific Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Applikon Biotechnology
2.2.1 Applikon Biotechnology Details
2.2.2 Applikon Biotechnology Major Business
2.2.3 Applikon Biotechnology Single-Use Technologies for the Biologic Product and Solutions
2.2.4 Applikon Biotechnology Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Applikon Biotechnology Recent Developments and Future Plans
2.3 GE Healthcare
2.3.1 GE Healthcare Details
2.3.2 GE Healthcare Major Business
2.3.3 GE Healthcare Single-Use Technologies for the Biologic Product and Solutions
2.3.4 GE Healthcare Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 GE Healthcare Recent Developments and Future Plans
2.4 Pall
2.4.1 Pall Details
2.4.2 Pall Major Business
2.4.3 Pall Single-Use Technologies for the Biologic Product and Solutions
2.4.4 Pall Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Pall Recent Developments and Future Plans
2.5 BioPure Technology
2.5.1 BioPure Technology Details
2.5.2 BioPure Technology Major Business
2.5.3 BioPure Technology Single-Use Technologies for the Biologic Product and Solutions
2.5.4 BioPure Technology Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 BioPure Technology Recent Developments and Future Plans
2.6 Sartorius
2.6.1 Sartorius Details
2.6.2 Sartorius Major Business
2.6.3 Sartorius Single-Use Technologies for the Biologic Product and Solutions
2.6.4 Sartorius Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Sartorius Recent Developments and Future Plans
2.7 Novasep
2.7.1 Novasep Details
2.7.2 Novasep Major Business
2.7.3 Novasep Single-Use Technologies for the Biologic Product and Solutions
2.7.4 Novasep Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Novasep Recent Developments and Future Plans
2.8 W. L. Gore and Associates
2.8.1 W. L. Gore and Associates Details
2.8.2 W. L. Gore and Associates Major Business
2.8.3 W. L. Gore and Associates Single-Use Technologies for the Biologic Product and Solutions
2.8.4 W. L. Gore and Associates Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 W. L. Gore and Associates Recent Developments and Future Plans
2.9 EMD Millipore
2.9.1 EMD Millipore Details
2.9.2 EMD Millipore Major Business
2.9.3 EMD Millipore Single-Use Technologies for the Biologic Product and Solutions
2.9.4 EMD Millipore Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 EMD Millipore Recent Developments and Future Plans
2.10 DowDuPont
2.10.1 DowDuPont Details
2.10.2 DowDuPont Major Business
2.10.3 DowDuPont Single-Use Technologies for the Biologic Product and Solutions
2.10.4 DowDuPont Single-Use Technologies for the Biologic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 DowDuPont Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Single-Use Technologies for the Biologic Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Single-Use Technologies for the Biologic Players Market Share in 2021
3.2.2 Top 10 Single-Use Technologies for the Biologic Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Single-Use Technologies for the Biologic Players Head Office, Products and Services Provided
3.4 Single-Use Technologies for the Biologic Mergers & Acquisitions
3.5 Single-Use Technologies for the Biologic New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Single-Use Technologies for the Biologic Revenue and Market Share by Type (2017-2022)
4.2 Global Single-Use Technologies for the Biologic Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Single-Use Technologies for the Biologic Revenue Market Share by Application (2017-2022)
5.2 Global Single-Use Technologies for the Biologic Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Single-Use Technologies for the Biologic Revenue by Type (2017-2028)
6.2 North America Single-Use Technologies for the Biologic Revenue by Application (2017-2028)
6.3 North America Single-Use Technologies for the Biologic Market Size by Country
6.3.1 North America Single-Use Technologies for the Biologic Revenue by Country (2017-2028)
6.3.2 United States Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
6.3.3 Canada Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
6.3.4 Mexico Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Single-Use Technologies for the Biologic Revenue by Type (2017-2028)
7.2 Europe Single-Use Technologies for the Biologic Revenue by Application (2017-2028)
7.3 Europe Single-Use Technologies for the Biologic Market Size by Country
7.3.1 Europe Single-Use Technologies for the Biologic Revenue by Country (2017-2028)
7.3.2 Germany Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
7.3.3 France Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
7.3.5 Russia Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
7.3.6 Italy Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Single-Use Technologies for the Biologic Revenue by Type (2017-2028)
8.2 Asia-Pacific Single-Use Technologies for the Biologic Revenue by Application (2017-2028)
8.3 Asia-Pacific Single-Use Technologies for the Biologic Market Size by Region
8.3.1 Asia-Pacific Single-Use Technologies for the Biologic Revenue by Region (2017-2028)
8.3.2 China Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
8.3.3 Japan Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
8.3.4 South Korea Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
8.3.5 India Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
8.3.7 Australia Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Single-Use Technologies for the Biologic Revenue by Type (2017-2028)
9.2 South America Single-Use Technologies for the Biologic Revenue by Application (2017-2028)
9.3 South America Single-Use Technologies for the Biologic Market Size by Country
9.3.1 South America Single-Use Technologies for the Biologic Revenue by Country (2017-2028)
9.3.2 Brazil Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
9.3.3 Argentina Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Single-Use Technologies for the Biologic Revenue by Type (2017-2028)
10.2 Middle East & Africa Single-Use Technologies for the Biologic Revenue by Application (2017-2028)
10.3 Middle East & Africa Single-Use Technologies for the Biologic Market Size by Country
10.3.1 Middle East & Africa Single-Use Technologies for the Biologic Revenue by Country (2017-2028)
10.3.2 Turkey Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
10.3.4 UAE Single-Use Technologies for the Biologic Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Single-Use Technologies for the Biologic Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Single-Use Technologies for the Biologic Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Single-Use Technologies for the Biologic Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Single-Use Technologies for the Biologic Revenue (USD Million) by Region (2017-2022)
Table 5. Global Single-Use Technologies for the Biologic Revenue Market Share by Region (2023-2028)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific Single-Use Technologies for the Biologic Product and Solutions
Table 9. Thermo Fisher Scientific Single-Use Technologies for the Biologic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Applikon Biotechnology Corporate Information, Head Office, and Major Competitors
Table 11. Applikon Biotechnology Major Business
Table 12. Applikon Biotechnology Single-Use Technologies for the Biologic Product and Solutions
Table 13. Applikon Biotechnology Single-Use Technologies for the Biologic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 15. GE Healthcare Major Business
Table 16. GE Healthcare Single-Use Technologies for the Biologic Product and Solutions
Table 17. GE Healthcare Single-Use Technologies for the Biologic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Pall Corporate Information, Head Office, and Major Competitors
Table 19. Pall Major Business
Table 20. Pall Single-Use Technologies for the Biologic Product and Solutions
Table 21. Pall Single-Use Technologies for the Biologic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. BioPure Technology Corporate Information, Head Office, and Major Competitors
Table 23. BioPure Technology Major Business
Table 24. BioPure Technology Single-Use Technologies for the Biologic Product and Solutions
Table 25. BioPure Technology Single-Use Technologies for the Biologic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Sartorius Corporate Information, Head Office, and Major Competitors
Table 27. Sartorius Major Business
Table 28. Sartorius Single-Use Technologies for the Biologic Product and Solutions
Table 29. Sartorius Single-Use Technologies for the Biologic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Novasep Corporate Information, Head Office, and Major Competitors
Table 31. Novasep Major Business
Table 32. Novasep Single-Use Technologies for the Biologic Product and Solutions
Table 33. Novasep Single-Use Technologies for the Biologic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. W. L. Gore and Associates Corporate Information, Head Office, and Major Competitors
Table 35. W. L. Gore and Associates Major Business
Table 36. W. L. Gore and Associates Single-Use Technologies for the Biologic Product and Solutions
Table 37. W. L. Gore and Associates Single-Use Technologies for the Biologic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. EMD Millipore Corporate Information, Head Office, and Major Competitors
Table 39. EMD Millipore Major Business
Table 40. EMD Millipore Single-Use Technologies for the Biologic Product and Solutions
Table 41. EMD Millipore Single-Use Technologies for the Biologic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. DowDuPont Corporate Information, Head Office, and Major Competitors
Table 43. DowDuPont Major Business
Table 44. DowDuPont Single-Use Technologies for the Biologic Product and Solutions
Table 45. DowDuPont Single-Use Technologies for the Biologic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Single-Use Technologies for the Biologic Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Single-Use Technologies for the Biologic Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Single-Use Technologies for the Biologic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Single-Use Technologies for the Biologic Players Head Office, Products and Services Provided
Table 50. Single-Use Technologies for the Biologic Mergers & Acquisitions in the Past Five Years
Table 51. Single-Use Technologies for the Biologic New Entrants and Expansion Plans
Table 52. Global Single-Use Technologies for the Biologic Revenue (USD Million) by Type (2017-2022)
Table 53. Global Single-Use Technologies for the Biologic Revenue Share by Type (2017-2022)
Table 54. Global Single-Use Technologies for the Biologic Revenue Forecast by Type (2023-2028)
Table 55. Global Single-Use Technologies for the Biologic Revenue by Application (2017-2022)
Table 56. Global Single-Use Technologies for the Biologic Revenue Forecast by Application (2023-2028)
Table 57. North America Single-Use Technologies for the Biologic Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Single-Use Technologies for the Biologic Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Single-Use Technologies for the Biologic Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Single-Use Technologies for the Biologic Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Single-Use Technologies for the Biologic Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Single-Use Technologies for the Biologic Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Single-Use Technologies for the Biologic Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Single-Use Technologies for the Biologic Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Single-Use Technologies for the Biologic Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Single-Use Technologies for the Biologic Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Single-Use Technologies for the Biologic Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Single-Use Technologies for the Biologic Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Single-Use Technologies for the Biologic Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Single-Use Technologies for the Biologic Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Single-Use Technologies for the Biologic Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Single-Use Technologies for the Biologic Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Single-Use Technologies for the Biologic Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Single-Use Technologies for the Biologic Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Single-Use Technologies for the Biologic Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Single-Use Technologies for the Biologic Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Single-Use Technologies for the Biologic Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Single-Use Technologies for the Biologic Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Single-Use Technologies for the Biologic Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Single-Use Technologies for the Biologic Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Single-Use Technologies for the Biologic Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Single-Use Technologies for the Biologic Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Single-Use Technologies for the Biologic Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Single-Use Technologies for the Biologic Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Single-Use Technologies for the Biologic Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Single-Use Technologies for the Biologic Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Single-Use Technologies for the Biologic Picture
Figure 2. Global Single-Use Technologies for the Biologic Revenue Market Share by Type in 2021
Figure 3. Membrane Adsorber
Figure 4. Bioreactors
Figure 5. Disposable Mixing Systems
Figure 6. Tangential Flow Filtration
Figure 7. Tubing and Connectors
Figure 8. Depth Filtration
Figure 9. Buffer Containers
Figure 10. Waste Containers
Figure 11. Single-Use Technologies for the Biologic Revenue Market Share by Application in 2021
Figure 12. Monoclonal Antibodies Picture
Figure 13. Vaccines Picture
Figure 14. Gene Therapy Picture
Figure 15. Recombinant Proteins Picture
Figure 16. Blood Derivatives Picture
Figure 17. Global Single-Use Technologies for the Biologic Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 18. Global Single-Use Technologies for the Biologic Revenue and Forecast (2017-2028) & (USD Million)
Figure 19. Global Single-Use Technologies for the Biologic Revenue Market Share by Region (2017-2028)
Figure 20. Global Single-Use Technologies for the Biologic Revenue Market Share by Region in 2021
Figure 21. North America Single-Use Technologies for the Biologic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Europe Single-Use Technologies for the Biologic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Asia-Pacific Single-Use Technologies for the Biologic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. South America Single-Use Technologies for the Biologic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 25. Middle East and Africa Single-Use Technologies for the Biologic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 26. Single-Use Technologies for the Biologic Market Drivers
Figure 27. Single-Use Technologies for the Biologic Market Restraints
Figure 28. Single-Use Technologies for the Biologic Market Trends
Figure 29. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 30. Applikon Biotechnology Recent Developments and Future Plans
Figure 31. GE Healthcare Recent Developments and Future Plans
Figure 32. Pall Recent Developments and Future Plans
Figure 33. BioPure Technology Recent Developments and Future Plans
Figure 34. Sartorius Recent Developments and Future Plans
Figure 35. Novasep Recent Developments and Future Plans
Figure 36. W. L. Gore and Associates Recent Developments and Future Plans
Figure 37. EMD Millipore Recent Developments and Future Plans
Figure 38. DowDuPont Recent Developments and Future Plans
Figure 39. Global Single-Use Technologies for the Biologic Revenue Share by Players in 2021
Figure 40. Single-Use Technologies for the Biologic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Single-Use Technologies for the Biologic Revenue Market Share in 2021
Figure 42. Global Top 10 Players Single-Use Technologies for the Biologic Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Single-Use Technologies for the Biologic Revenue Share by Type in 2021
Figure 45. Global Single-Use Technologies for the Biologic Market Share Forecast by Type (2023-2028)
Figure 46. Global Single-Use Technologies for the Biologic Revenue Share by Application in 2021
Figure 47. Global Single-Use Technologies for the Biologic Market Share Forecast by Application (2023-2028)
Figure 48. North America Single-Use Technologies for the Biologic Sales Market Share by Type (2017-2028)
Figure 49. North America Single-Use Technologies for the Biologic Sales Market Share by Application (2017-2028)
Figure 50. North America Single-Use Technologies for the Biologic Revenue Market Share by Country (2017-2028)
Figure 51. United States Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Single-Use Technologies for the Biologic Sales Market Share by Type (2017-2028)
Figure 55. Europe Single-Use Technologies for the Biologic Sales Market Share by Application (2017-2028)
Figure 56. Europe Single-Use Technologies for the Biologic Revenue Market Share by Country (2017-2028)
Figure 57. Germany Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Single-Use Technologies for the Biologic Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Single-Use Technologies for the Biologic Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Single-Use Technologies for the Biologic Revenue Market Share by Region (2017-2028)
Figure 65. China Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Single-Use Technologies for the Biologic Sales Market Share by Type (2017-2028)
Figure 72. South America Single-Use Technologies for the Biologic Sales Market Share by Application (2017-2028)
Figure 73. South America Single-Use Technologies for the Biologic Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Single-Use Technologies for the Biologic Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Single-Use Technologies for the Biologic Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Single-Use Technologies for the Biologic Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Single-Use Technologies for the Biologic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
